Organization
Peking University Shenzhen Hospital
3 clinical trials
5 abstracts
Abstract
A phase Ib study of PI3Kα inhibitor risovalisib mesylate in combination with fulvestrant in patients with PIK3CA-mutated, HR+/HER2- advanced breast cancer.Org: Fudan University Shanghai Cancer Center, The Second Hospital of Dalian Medical University, Harbin Medical University Cancer Hospital, Liaoning Cancer Hospital & Institute, Shenyang, China, Hunan Cancer Hospital,
Abstract
A single-arm, multicenter, phase II study of utidelone in advanced solid tumors: Efficacy data from screening and the expansion cohort assessing utidelone plus sintilimab and oxaliplatin for advanced gastric cancer.Org: Peking University Shenzhen Hospital, Beijing Obstetrics and Gynecolgoy Hospital, Capital Medical University, Beijing, China, Beijing Biostar Pharmaceuticals,
Abstract
Assessment of plasma cell-free DNA fragmentation for multi-cancer early detection: An independent clinical validation study.Org: HaploX Biotechnology, Shenzhen, China, Department of Clinical Laboratory, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, Peking University Shenzhen Hospital,
Clinical trial
Medical Ethics Committee of Peking University Shenzhen HospitalStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Prospective, Case-controlled Randomized Study of Human Reproductive Tract Active Lactobacillus in Adjuvant Treatment of Recurrent Vulvovaginal Candidiasis.Status: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Department of Obstetrics and Gynecology, Peking University Shenzhen HospitalStatus: Recruiting, Estimated PCD: 2024-12-01
Abstract
Utilize protein markers and genomic features for minimal residual disease detection in hepatocellular carcinoma.Org: Clinical Laboratories, Shenyou Bio, Zhengzhou Gensciences, China National Biotec Group, SeekIn Inc.,
Abstract
A differential analysis of TCR repertoire between patients with EGFR-mutant and KRAS-mutant non–small-cell lung cancer.Org: Peking University Shenzhen Hospital, HaploX Biotechnology Co., Ltd., Shenzhen, China, HaploX Biotechnology, Shenzhen, China, HaploX Biotechnology Co. Ltd.,